Occlusion of the left atrial appendage (LAA) in patients with atrial fibrillation has become a standard therapy to prevent thromboembolic complications. We aim to present 3 cases of LAA occluder embolization after percutaneous WATCHMAN TM device implantation, which required emergent surgical retrieval. The device was dislocated in the left atrium, introducing LAA perforation and resulting in pericardial effusion and later tamponade in 1 patient who developed multiorgan failure and died 8 days postoperatively. Other patients were successfully operated and discharged. Hence, LAA occluder embolization may occur asymptomatically with immediate/late serious complications, which indicates emergent surgery.
INTRODUCTION
Atrial fibrillation (AF) is the most common arrhythmia in Western countries, which increases the risk of stroke. One of the milestones in avoiding cerebrovascular events in those patients is the application of oral anticoagulants (OACs) or non-vitamin K OACs. However, OACs are associated with bleeding complications, which require close monitoring and patient compliance. In patients with non-valvular AF, embolic stroke has been demonstrated to be associated with left atrial appendage (LAA) thrombi. So far, different interventional and surgical techniques have been developed for LAA occlusion. We hereby present 3 cases of the WATCHMAN TM device embolization, requiring emergent surgical retrieval.
RESULTS

First patient
An 82-year-old male patient presented with paroxysmal AF (a CHA 2 DS 2 -VASc score of 5) and a history of stroke with residual left-sided hemiparesis. Due to gastrointestinal bleeding, OACs and non-vitamin K OACs were contraindicated. Thus, a percutaneous LAA closure with a 21-mm WATCHMAN device was considered, as the LAA orifice diameter was 17 mm. During implantation, LAA perforation occurred, leading to pericardial effusion, which was initially managed with percutaneous pericardial puncture and draining; however, the patient's haemodynamics became unstable and was transferred to emergent surgery. A standard surgery with cardiopulmonary bypass was initiated. The device was removed via left atriotomy, and the LAA was closed with a double-layer running suture. Although the surgery was successful, the patient developed a low-cardiac output syndrome on top of right-sided heart failure, leading to subsequent multiorgan failure and death.
Second patient
An 85-year-old male patient presented with paroxysmal AF (a CHA 2 DS 2 -VASc score of 4) and a history of coronary artery disease with multiple stents. Oral anticoagulation was stopped due to gastrointestinal bleeding. Therefore, a successful percutaneous implantation of a 30-mm WATCHMAN device was performed. However, 3 months later, the patient was rehospitalized due to dyspnoea. Echocardiography showed device migration into the left ventricular outflow tract causing mild mitral regurgitation and subvalvular aortic stenosis and was referred for surgery. A standard surgery and careful device removal via aortotomy, without harming the mitral valve and LAA closure with a double-layer suture, was performed. The postoperative course was uneventful.
Third patient
A 76-year-old male patient presented with permanent AF (a CHA 2 DS 2 -VASc score of 3). Oral anticoagulation was contraindicated due to haemoptysis caused by liver cirrhosis. Therefore, percutaneous LAA closure was performed using a 24-mm WATCHMAN device. One year later, the patient was rehospitalized due to dyspnoea and pneumonia. Echocardiography revealed moderate native aortic stenosis and migration of the device into the left ventricular outflow tract, leading to moderate mitral regurgitation and the patient was referred for surgery. A standard surgery was established, where the aortic valve was excised, removing the device, which was fused into the anterior mitral leaflet (Fig. 1A and B) , so subsequent mitral valve repair, aortic valve replacement and LAA closure were performed. Preoperative pneumonia prolonged hospital stay, and the patient was discharged 3 weeks later.
COMMENT
Currently, several LAA occluder devices have been developed for non-valvular atrial fibrillation patients, either percutaneously such as the WATCHMAN device (Boston Scientific Corp., Marlborough, MA, USA) or surgically such as the AtriClip device (AtriCure, West Chester, OH, USA), which has a reported success rate of more than 95% [1] . The use of percutaneous devices was associated with various complications such as vascular complications, oesophageal injury, procedure-related stroke, device thrombus or cardiac perforation [2] , in addition to the incidence of leaks after implantation, which have been reported in 17% of patients in a recent study [3] . Although migration of the LAA occluder device is a rare complication, it is often life-threatening. It occurs mainly in the periprocedural period, but late embolization has been also described [2] .
Our case series reports 3 cases of WATCHMAN complications. In general, our series emphasize several important points: timing of embolization in the last 2 cases could not be defined, which meant that dislocation of the device could have been asymptomatic. Although periprocedural complications are rare, it might end up in a lethal outcome due to cardiac perforation as shown in the first case. Device embolization in the left ventricle requires urgent surgery because percutaneous extraction is challenging due to surrounding structures. Finally, some mechanisms have been described as the potential causes for device migration, such as device under-or oversizing and rhythm conversion during the procedure. The 2 patients in our series who presented with paroxysmal AF and sinus rhythm at the time of surgery might support the notion that atrial contraction could also provoke device displacement [4] .
